Which of the following conditions indicates the use of iron sucrose in pregnant women?

NHM MP Staff Nurse-2019

Obstetrics & Gynaecology

Medium

Appeared in: NHM MP Staff Nurse-2019

Explanation

A hemoglobin (Hb) level below 7 gm% in a pregnant woman is classified as severe anemia.
Severe anemia is a primary indication for intravenous (IV) iron therapy, such as iron sucrose, to ensure rapid correction of iron levels.
Oral iron is often too slow or poorly tolerated in cases of severe anemia, especially in the late second or third trimester.
Rapidly treating severe anemia is critical to prevent complications like preterm birth, low birth weight, and to prepare the mother for potential blood loss during delivery.

Option A: This level (less than 10 gm%) falls into the category of mild to moderate anemia. The standard first-line treatment for this is oral iron supplementation.
Option B: This represents critically severe anemia. While IV iron is part of the management, the most urgent intervention is typically a blood transfusion to prevent cardiovascular collapse and ensure immediate oxygen delivery.
Option D: This level (less than 9 gm%) is considered moderate anemia. The initial treatment of choice is oral iron supplementation.

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Indications for IV Iron Therapy in Pregnancy as background academic context rather than a clinical decision trigger.
Treating maternal anemia is crucial as it is linked to adverse outcomes such as preterm delivery, low birth weight, and increased perinatal mortality. It also impacts the mother's health, increasing fatigue and risk of postpartum hemorrhage.
Nurses play a vital role in administering IV iron infusions, which requires careful monitoring for adverse reactions like hypotension, flushing, or anaphylaxis. A slow infusion rate and close observation are key safety measures.
What if? If a patient with a hemoglobin of 8.5 gm% (moderate anemia) is in her first trimester, the correct action would be to start oral iron therapy. There is ample time for the oral route to be effective before delivery, making IV iron unnecessary as a first-line treatment.

How to Approach the Question

First, identify the key elements of the question: the intervention (iron sucrose), the patient population (pregnant women), and the clinical parameter (hemoglobin level).
Recall the standard medical guidelines for classifying and treating anemia during pregnancy.
Recognize that different levels of anemia severity warrant different treatment approaches (oral vs. intravenous vs. transfusion).
Evaluate each option based on these guidelines. A hemoglobin level of less than 7 gm% defines severe anemia.
Conclude that severe anemia is the strongest and most direct indication for initiating IV iron therapy like iron sucrose among the choices provided.

Concept Tested & Keywords

Qgcam_Mr8Ef80JAtQrrf1c

E6 Parks TextBook of Preventive & Social Medicine part 2 — Subpart A (pp 1-232 of 464) p. 158-160

E6 Medicine Harrison 22e Part 1 p. 807-809